Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase.
Chris J. Vlahos(Eli Lilly (United States)), William F. Matter(Eli Lilly (United States)), Alexis Traynor‐Kaplan(Eli Lilly (United States)), Philip Marder(Eli Lilly (United States)), Raymond F. Brown(Eli Lilly (United States)), Kimberly J. Rothfuss(Eli Lilly (United States)), Eric R. Prossnitz(University of New Mexico), J A Schelm(Eli Lilly (United States)), R D Ye(Scripps Research Institute), P G Heyworth(University of Iowa)
Cited by 174
Related Papers
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
|Journal of Biological Chemistry|1994|3.3k
Increased Protein Kinase C Activity and Expression of Ca <sup>2+</sup> -Sensitive Isoforms in the Failing Human Heart
|Circulation|1999|457
Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558.
|Journal of Clinical Investigation|1991|372
Decreased Cardiac Expression of Vascular Endothelial Growth Factor and Its Receptors in Insulin-Resistant and Diabetic States
|Circulation|2002|338
Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives
|The Journal of Steroid Biochemistry and Molecular Biology|2017|245